Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3217836
Max Phase: Preclinical
Molecular Formula: C35H40N8O4
Molecular Weight: 636.76
Molecule Type: Protein
Associated Items:
ID: ALA3217836
Max Phase: Preclinical
Molecular Formula: C35H40N8O4
Molecular Weight: 636.76
Molecule Type: Protein
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1ccccc1
Standard InChI: InChI=1S/C35H40N8O4/c36-27(13-8-16-39-35(37)38)32(44)42-30(17-23-19-40-28-14-6-4-11-25(23)28)33(45)43-31(34(46)47-21-22-9-2-1-3-10-22)18-24-20-41-29-15-7-5-12-26(24)29/h1-7,9-12,14-15,19-20,27,30-31,40-41H,8,13,16-18,21,36H2,(H,42,44)(H,43,45)(H4,37,38,39)/t27-,30-,31-/m0/s1
Standard InChI Key: UJJWKXTWEXCQFS-NAYUSWPISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 636.76 | Molecular Weight (Monoisotopic): 636.3173 | AlogP: 2.74 | #Rotatable Bonds: 15 |
Polar Surface Area: 204.00 | Molecular Species: BASE | HBA: 6 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.19 | CX Basic pKa: 11.82 | CX LogP: 2.44 | CX LogD: -0.12 |
Aromatic Rings: 5 | Heavy Atoms: 47 | QED Weighted: 0.04 | Np Likeness Score: 0.07 |
1. Liu L, Wei L, Yang Y, Zhao M, Zhang X, Zheng M, Wang Y, Peng S. (2011) A class of novel AA-Trp-Trp-OBzl: synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and intercalation mechanism, 2 (2): [10.1039/C0MD00208A] |
Source(1):